Sourcing R&D innovation: why pharma companies need to evolve their business models
The global pharmaceutical and biotechnology industries have achieved many significant milestones in innovative research and drug development in the past decade...
Emre Vural is an associate principal in the Life Sciences practice of CRA based in San Francisco. He has nine years of experience in management and strategy consulting with a focus on healthcare industry commercial issues.
Prior to joining CRA, Emre was a consultant with the Boston Consulting Group’s Istanbul office, serving clients in healthcare, telecommunications, and finance industries in Europe and the Middle East.
Prior to joining BCG, he conducted various healthcare commercialization projects (EU5 market landscaping, launch pricing research, real-world evidence, and digital health commercialization) as an independent consultant. Previously, he spent five years as a project manager in the Pricing and Market Access Center of Excellence at IMS Consulting Group (now IQVIA) in New York, where he lead global project teams consulting on market landscaping, stakeholder mapping, pricing across product lifecycle, clinical trials strategy, emerging markets expansion, contracting strategy, and innovative pricing schemes, among other commercial issues.